Product’s Details:

• Ndvone (edaravone 1.5 mg/mL) is an injectable neuroprotective agent indicated mainly for early-stage ALS. Given in cyclical IV infusions over 60 minutes, it helps slow functional decline.
• Safety considerations include allergic reactions, side effects like headache and bruising and limited reproductive safety data. Use requires specialist oversight and strict infusion protocols.
• Precautions:
  • Requires neurologist prescription and administration in specialized infusion clinics.
  • Monitor closely for allergic reactions (rash, swelling, breathing difficulty)
• Common Side Effects:
  • Headache
  • Bruising at injection site
  • Skin rash or itching
  • Allergic reaction
• Storage:
  • Store in a cool place as per manufacturer’s instructions
  • Protect from light
  • Do not freeze
  • Single-use vials